Page last updated: 2024-09-03

tamsulosin and Bladder, Overactive

tamsulosin has been researched along with Bladder, Overactive in 64 studies

Research

Studies (64)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's22 (34.38)29.6817
2010's29 (45.31)24.3611
2020's13 (20.31)2.80

Authors

AuthorsStudies
Fujita, H; Imai, S; Imai, Y; Kamo, I; Kohara, Y; Kuno, H; Nagabukuro, H; Okabe, Y; Saikawa, R; Sakauchi, N; Sato, A; Suzaki, T; Yoshida, M1
Jong, JJ; Kakizaki, H; Katou, D; Lee, KS; Sumarsono, B; Uno, S; Yamaguchi, O; Yamamoto, O1
Cambronero Santos, J; Chapple, C; Choudhury, N; Foley, S; Hairston, J; Herschorn, S; Kaplan, SA; Kristy, RM; McVary, KT; Schermer, CR; Staskin, D1
Sahin, A; Urkmez, A; Yildirim, C; Yuksel, OH1
Chen, Z; Gao, Y; Liang, L; Lin, J; Liu, L; Su, S1
Peyronnet, B1
El-Abd, AS; El-Abd, SA; Radwan, MH; Soliman, MG; Tawfik, AM1
Ishida, K; Jong, JJ; Kakizaki, H; Katoh, T; Katou, D; Lee, KS; Sumarsono, B; Uno, S; Yamaguchi, O; Yamamoto, O1
Cambronero Santos, J; Choudhury, N; Foley, S; Hairston, J; Herschorn, S; Kaplan, SA; Kristy, RM; McVary, KT1
Kakizaki, H; Katou, D; Lee, KS; Sumarsono, B; Uno, S; Yamaguchi, O; Yamamoto, O1
Brucker, B; Bschleipfer, T; Cornu, JN; De Nunzio, C; Drake, MJ; Fusco, F; Gravas, S; Madersbacher, S; Oelke, M; Peyronnet, B; Tutolo, M; van Koeveringe, G1
Burgio, KL; Falk, K; Goode, PS; Hammontree, L; Johnson, TM; Markland, AD; McGwin, G; Ouslander, JG; Vaughan, CP1
Asakura, H; Seki, N; Tokunaga, S; Yamanishi, T3
Behera, DP; Gupta, S; Singh, I; T K, A1
Krivoborodov, GG; Tur, EI1
Gainullina, Y; Kosilov, K; Kosilova, L; Kuzina, I; Kuznetsov, V; Loparev, S; Prokofyeva, A1
Apostolidis, A; Papathanasiou, A; Sakalis, V; Salpiggidis, G; Sfiggas, V; Vouros, I1
De Wachter, S; Foley, S; Huang, M; Rees, J; Rosa Arias, J; Skoumal, R; Walters, C; Yavuz, Y1
Gotoh, M; Masumori, N; Nishizawa, O; Takahashi, S; Takeda, M; Yoshida, M1
Byun, SS; Kim, KH; Lee, JY; Lee, SH; Lee, SJ1
Gao, ZW; Li, HB; Ren, XQ; Shang, YF; Shao, CS; Xiao, F; Xin, SY; Zhang, JG; Zhang, W1
Li, J; Liu, B; Wang, Y; Wu, Y1
Chapple, C; Drake, MJ; Drogendijk, T; Klaver, M; Oelke, M; Sokol, R; Traudtner, K; Van Kerrebroeck, P1
Ivanovskaya, M; Kosilov, K; Kosilova, L; Loparev, S1
Doo, SW; Kim, JH; Lee, SW; Yang, HJ; Yang, WJ; Yun, JH1
Fukuta, F; Ichihara, K; Iwasawa, A; Masumori, N; Tanaka, Y; Tsukamoto, T1
Chung, BH; Hong, S; Kim, CS; Kim, DK; Kim, JC; Lee, JG; Lee, KS; Lee, YS; Park, CH; Park, JK1
Chung, BH; Hong, SJ; Kim, CS; Kim, DK; Kim, JC; Lee, HN; Lee, JG; Lee, KS; Park, CH; Park, JK1
Bae, SR; Cho, SY; Han, CH; Hur, KJ; Kim, HW; Kim, SH; Lee, KW; Lee, YS; Park, BH1
Ito, N; Kamiyama, Y; Kanamaru, S; Kawakita, M; Matsumoto, K; Muguruma, K; Shirahase, T; Takahashi, T; Tsukazaki, H; Tsunemori, H; Utsunomiya, N1
Hashizume, K; Iuchi, H; Kakizaki, H; Kita, M; Matsumoto, S; Wada, N1
Choi, IS; Park, JK; Shin, YS; You, JH; Zhang, LT; Zhao, C1
Kosilov, K; Kuzina, I; Lobodenko, A; Loparev, S; Shakirova, O; Zhuravskaya, N1
Bavendam, T; Carlsson, M; Chancellor, M; Guan, Z; Kaplan, SA; Roehrborn, CG1
Porru, D1
Bavendam, T; Guan, Z; Jones, JS; Kaplan, SA; Roehrborn, CG; Wang, JT1
Wyndaele, JJ1
Matsumoto, S; Uemura, H1
Bavendam, T; Carlsson, M; Guan, Z; Kaplan, SA; Kreder, K; Rovner, ES; Sussman, DO1
Chiu, B; Chuang, YC; Chung, SD; Kuo, HC1
Aquilina, JW; Armstrong, RB; Chen, A; MacDiarmid, SA; Nitti, VW; Orman, C; Peters, KM1
Bavendam, T; Guan, Z; Kaplan, SA; Kraus, SR; Roehrborn, CG; Wang, JT1
Aizawa, N; Andersson, KE; Chen, Z; Igawa, Y; Imamura, T; Ishizuka, O; Nishizawa, O1
Fakhoury, A; Fincher, R; He, W; Kaplan, SA; McCammon, K1
Kadekawa, K; Miyazato, M; Mukouyama, H; Nishijima, S; Sugaya, K1
Becher, E; Gagnier, RP; Montorsi, F; Roehrborn, CG; Siami, P; Wilson, TH1
Yokoyama, O1
Gärtner, M; Havránek, O; Krhut, J; Nemec, D; Tvrdík, J1
Gotoh, M; Homma, Y; Kakizaki, H; Nishizawa, O; Seki, N; Takeda, M; Yamaguchi, O; Yokoyama, O; Yoshida, M1
Fukuhara, S; Higashino, M; Hirai, T; Kanno, N; Kiuchi, H; Miura, H; Miyagawa, Y; Nakamura, Y; Nakayama, J; Nishimura, K; Nonomura, N; Okuda, H; Takao, T; Tsujimoto, Y; Tsujimura, A; Ueda, T; Yamamoto, K1
Akino, H; Aoki, Y; Ito, H; Nagase, K; Tanase, K; Yokoyama, O1
Gotoh, M1
Matsumoto, S; Ohtake, A; Okutsu, H; Sasamata, M; Sato, S; Suzuki, M; Uemura, H1
Cerqueira, JB; de Moraes, MO; Jamacaru, FV; Josino, IR; Nogueira, EA; Regadas, RP; Reges, R; Silva, LF; Sucupira, DG1
Arunkalaivanan, A; Sinha, D1
Bavendam, T; Carlsson, M; Guan, Z; Kaplan, SA; Roehrborn, CG; Rovner, ES1
Chugh, A; Malhotra, S; Mittra, S; Naruganahalli, KS1
Subramonian, K; Young, JG1
Amarshi, N; Bell, WA1
Abe, K; Egaway, S; Furuta, A; Ikemoto, I; Kishimoto, K; Kiyota, H; Kosugi, S; Shimomura, T; Shirai, H; Suzuki, Y; Takeuchi, H; Torii, S1
Bolodeoku, J; Cardozo, L; Robinson, D; Terpstra, G1
Akino, H; Aoki, Y; Ito, H; Miwa, Y; Oyama, N; Yokoyama, O1

Reviews

4 review(s) available for tamsulosin and Bladder, Overactive

ArticleYear
The efficacy and safety of mirabegron on overactive bladder induced by benign prostatic hyperplasia in men receiving tamsulosin therapy: A systematic review and meta-analysis.
    Medicine, 2020, Volume: 99, Issue:4

    Topics: Acetanilides; Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-3 Receptor Agonists; Humans; Male; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Tamsulosin; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive

2020
Beyond Antimuscarinics: A Review of Pharmacological and Interventional Options for Overactive Bladder Management in Men.
    European urology, 2021, Volume: 79, Issue:4

    Topics: Acetanilides; Botulinum Toxins, Type A; Female; Humans; Male; Muscarinic Antagonists; Phosphodiesterase 5 Inhibitors; Tamsulosin; Treatment Outcome; Urinary Bladder, Overactive

2021
[Comprehensive pharmacologic management of overactive bladder].
    Urologiia (Moscow, Russia : 1999), 2017, Issue:1

    Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Drug Combinations; Humans; Muscarinic Antagonists; Randomized Controlled Trials as Topic; Solifenacin Succinate; Sulfonamides; Tamsulosin; Thiazoles; Urinary Bladder, Neurogenic; Urinary Bladder, Overactive

2017
[Clinical effectiveness and safety of combined therapy with alpha-blocker and an anticholinergic drug for bladder outlet obstruction with overactive bladder: a Meta-analysis of outcomes].
    Zhonghua wai ke za zhi [Chinese journal of surgery], 2014, Volume: 52, Issue:5

    Topics: Adrenergic alpha-Antagonists; Cholinergic Antagonists; Drug Therapy, Combination; Humans; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Bladder Neck Obstruction; Urinary Bladder, Overactive

2014

Trials

35 trial(s) available for tamsulosin and Bladder, Overactive

ArticleYear
Mirabegron Add-on Therapy to Tamsulosin for the Treatment of Overactive Bladder in Men with Lower Urinary Tract Symptoms: A Randomized, Placebo-controlled Study (MATCH).
    European urology focus, 2020, 07-15, Volume: 6, Issue:4

    Topics: Acetanilides; Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-3 Receptor Agonists; Aged; Double-Blind Method; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Single-Blind Method; Tamsulosin; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive

2020
Efficacy and Safety of Mirabegron versus Placebo Add-On Therapy in Men with Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Randomized, Phase 4 Study (PLUS).
    The Journal of urology, 2020, Volume: 203, Issue:6

    Topics: Acetanilides; Adult; Aged; Aged, 80 and over; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Humans; Male; Middle Aged; Prostatic Hyperplasia; Tamsulosin; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents

2020
Treatment of ureteral catheter related symptoms; mirabegron versus tamsulosin/solifenacin combination: A randomized controlled trial.
    Archivos espanoles de urologia, 2020, Volume: 73, Issue:1

    Topics: Acetanilides; Adult; Drug Therapy, Combination; Humans; Middle Aged; Quality of Life; Solifenacin Succinate; Tamsulosin; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive; Urinary Catheters; Urological Agents

2020
Efficacy and safety of mirabegron versus solifenacin as additional therapy for persistent OAB symptoms after tamsulosin monotherapy in men with probable BPO.
    World journal of urology, 2021, Volume: 39, Issue:6

    Topics: Acetanilides; Humans; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Single-Blind Method; Solifenacin Succinate; Tamsulosin; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive

2021
Cardiovascular safety of mirabegron add-on therapy to tamsulosin for the treatment of overactive bladder in men with lower urinary tract symptoms: A post hoc analysis from the MATCH study.
    Lower urinary tract symptoms, 2021, Volume: 13, Issue:1

    Topics: Acetanilides; Age Factors; Aged; Cardiovascular Diseases; Double-Blind Method; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Tamsulosin; Thiazoles; Urinary Bladder, Overactive

2021
Mirabegron Vs Placebo Add-on Therapy in Men With Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Safety Analysis From the Randomized, Phase 4 PLUS Study.
    Urology, 2021, Volume: 147

    Topics: Acetanilides; Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-3 Receptor Agonists; Adult; Aged; Double-Blind Method; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Tamsulosin; Thiazoles; Urinary Bladder, Overactive

2021
Mirabegron Add-On Therapy to Tamsulosin in Men with Overactive Bladder: Post Hoc Analyses of Efficacy from the MATCH Study.
    Advances in therapy, 2021, Volume: 38, Issue:1

    Topics: Acetanilides; Aged; Double-Blind Method; Drug Therapy, Combination; Humans; Male; Muscarinic Antagonists; Quality of Life; Single-Blind Method; Tamsulosin; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents

2021
An Exploratory Analysis of Tamsulosin for Overactive Bladder (OAB) in Men With Varying Voiding Symptom Burden.
    Urology, 2021, Volume: 153

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Cost of Illness; Humans; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Symptom Assessment; Tamsulosin; Treatment Outcome; Urinary Bladder, Overactive

2021
Triple Therapy with Tamsulosin, Dutasteride, and Imidafenacin for Benign Prostatic Hyperplasia in Patients with Overactive Bladder Symptoms Refractory to Tamsulosin: Subgroup Analyses of the DIrecT Study.
    Urologia internationalis, 2021, Volume: 105, Issue:9-10

    Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Drug Therapy, Combination; Dutasteride; Humans; Imidazoles; Japan; Male; Middle Aged; Muscarinic Antagonists; Prostatic Hyperplasia; Quality of Life; Recovery of Function; Tamsulosin; Time Factors; Treatment Outcome; Urinary Bladder, Overactive; Urodynamics; Urological Agents

2021
Efficacy and safety of tamsulosin vs its combination with mirabegron in the management of lower urinary tract non-neurogenic overactive bladder symptoms (OABS) because of Benign Prostatic Enlargement (BPE)-An open label randomised controlled clinical stud
    International journal of clinical practice, 2021, Volume: 75, Issue:7

    Topics: Acetanilides; Drug Therapy, Combination; Humans; Male; Prostatic Hyperplasia; Quality of Life; Tamsulosin; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive

2021
Efficacy and safety of combination therapy with tamsulosin, dutasteride and imidafenacin for the management of overactive bladder symptoms associated with benign prostatic hyperplasia: A multicenter, randomized, open-label, controlled trial (DIrecT Study)
    International journal of urology : official journal of the Japanese Urological Association, 2017, Volume: 24, Issue:7

    Topics: 5-alpha Reductase Inhibitors; Aged; Aged, 80 and over; Drug Therapy, Combination; Dutasteride; Humans; Imidazoles; Male; Middle Aged; Prostatic Hyperplasia; Quality of Life; Tamsulosin; Treatment Outcome; Urinary Bladder, Overactive

2017
Combination of solifenacin with tamsulosin reduces prostate volume and vascularity as opposed to tamsulosin monotherapy in patients with benign prostate enlargement and overactive bladder symptoms: Results from a randomized pilot study.
    International journal of urology : official journal of the Japanese Urological Association, 2018, Volume: 25, Issue:8

    Topics: Aged; Aged, 80 and over; Drug Therapy, Combination; Greece; Humans; Male; Middle Aged; Muscarinic Antagonists; Organ Size; Pilot Projects; Prospective Studies; Prostate; Prostatic Hyperplasia; Severity of Illness Index; Solifenacin Succinate; Tamsulosin; Urinary Bladder, Overactive; Urination

2018
A 52-week multicenter randomized controlled study of the efficacy and safety of add-on dutasteride and imidafenacin to tamsulosin in patients with benign prostatic hyperplasia with remaining overactive bladder symptoms (DIrecT study).
    Lower urinary tract symptoms, 2019, Volume: 11, Issue:3

    Topics: Aged; Aged, 80 and over; Drug Therapy, Combination; Dutasteride; Humans; Imidazoles; Male; Prostatic Hyperplasia; Severity of Illness Index; Tamsulosin; Urinary Bladder, Overactive; Urological Agents

2019
Clinical efficacy and safety of imidafenacin as add-on treatment for persistent overactive bladder symptoms despite α-blocker treatment in patients with BPH: the ADDITION study.
    Urology, 2013, Volume: 82, Issue:4

    Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Drug Therapy, Combination; Humans; Imidazoles; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urinary Bladder, Overactive

2013
Effects of initial combined tamsulosin and solifenacin therapy for overactive bladder and bladder outlet obstruction secondary to benign prostatic hyperplasia: a prospective, randomized, multicenter study.
    International urology and nephrology, 2014, Volume: 46, Issue:3

    Topics: Adrenergic alpha-Antagonists; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Prospective Studies; Prostatic Hyperplasia; Quinuclidines; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Urinary Bladder Neck Obstruction; Urinary Bladder, Overactive

2014
[Efficacy of combination therapy of tamsulosin and solifenacin for mild and moderate benign prostatic hyperplasia with overactive bladder].
    Zhonghua nan ke xue = National journal of andrology, 2014, Volume: 20, Issue:3

    Topics: Aged; Drug Therapy, Combination; Humans; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Quinuclidines; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Urinary Bladder, Overactive

2014
Long-term safety and efficacy of single-tablet combinations of solifenacin and tamsulosin oral controlled absorption system in men with storage and voiding lower urinary tract symptoms: results from the NEPTUNE Study and NEPTUNE II open-label extension.
    European urology, 2015, Volume: 67, Issue:2

    Topics: Administration, Oral; Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Chemistry, Pharmaceutical; Double-Blind Method; Drug Combinations; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Muscarinic Antagonists; Prostatic Hyperplasia; Solifenacin Succinate; Sulfonamides; Tablets; Tamsulosin; Time Factors; Treatment Outcome; Urinary Bladder; Urinary Bladder, Overactive; Urinary Retention; Urodynamics; Urological Agents

2015
Can we decide the optimal initial treatment for male lower urinary tract symptoms patients with overactive bladder by the most bothersome symptom? A randomized, prospective, open-label study.
    Urologia internationalis, 2014, Volume: 93, Issue:3

    Topics: Aged; Decision Making; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Muscarinic Antagonists; Prospective Studies; Prostate; Quality of Life; Quinuclidines; Republic of Korea; Solifenacin Succinate; Sulfonamides; Symptom Assessment; Tamsulosin; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urination

2014
A randomized controlled study of the efficacy of tamsulosin monotherapy and its combination with mirabegron for overactive bladder induced by benign prostatic obstruction.
    The Journal of urology, 2015, Volume: 193, Issue:3

    Topics: Acetanilides; Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-3 Receptor Agonists; Aged; Drug Therapy, Combination; Humans; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Thiazoles; Urinary Bladder, Overactive

2015
Rate and associated factors of solifenacin add-on after tamsulosin monotherapy in men with voiding and storage lower urinary tract symptoms.
    International journal of clinical practice, 2015, Volume: 69, Issue:4

    Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Prospective Studies; Quality of Life; Solifenacin Succinate; Sulfonamides; Tamsulosin; Urinary Bladder, Overactive; Urological Agents

2015
Initial Use of High-Dose Anticholinergics Combined with Alpha-Blockers for Male Lower Urinary Tract Symptoms with Overactive Bladder: A Prospective, Randomized Preliminary Study.
    Lower urinary tract symptoms, 2017, Volume: 9, Issue:3

    Topics: Adrenergic alpha-Antagonists; Aged; Cholinergic Antagonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Humans; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Solifenacin Succinate; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents

2017
[A Crossover Comparison Study on Lower Urinary Tract Symptoms with Overactive Bladder Secondary to Benign Prostatic Hyperplasia: Naftopidil versus Tamsulosin with Solifenacin].
    Hinyokika kiyo. Acta urologica Japonica, 2016, Volume: 62, Issue:7

    Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Cross-Over Studies; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Naphthalenes; Piperazines; Prostatic Hyperplasia; Quality of Life; Solifenacin Succinate; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Treatment Outcome; Urinary Bladder, Overactive

2016
Efficacy and safety of tamsulosin hydrochloride 0.2 mg and combination of tamsulosin hydrochloride 0.2 mg plus solifenacin succinate 5 mg after transurethral resection of the prostate: a prospective, randomized controlled trial.
    Clinical interventions in aging, 2016, Volume: 11

    Topics: Aged; Aged, 80 and over; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prospective Studies; Quality of Life; Solifenacin Succinate; Sulfonamides; Tamsulosin; Transurethral Resection of Prostate; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents

2016
The effective tool for self-assessment of adherence to treatment in patients with benign prostatic obstruction and overactive bladder symptoms.
    The aging male : the official journal of the International Society for the Study of the Aging Male, 2017, Volume: 20, Issue:1

    Topics: Aged; Benzilates; Diagnostic Self Evaluation; Drug Therapy, Combination; Humans; Male; Medication Adherence; Middle Aged; Muscarinic Antagonists; Nortropanes; Prostatic Hyperplasia; Self-Assessment; Solifenacin Succinate; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Urinary Bladder, Overactive

2017
Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
    BJU international, 2008, Volume: 102, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prostatic Hyperplasia; Prostatism; Quality of Life; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive

2008
Effect of tolterodine extended release with or without tamsulosin on measures of urgency and patient reported outcomes in men with lower urinary tract symptoms.
    The Journal of urology, 2008, Volume: 180, Issue:3

    Topics: Adrenergic alpha-Antagonists; Adult; Analysis of Variance; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Patient Satisfaction; Phenylpropanolamine; Prostatic Hyperplasia; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge

2008
Efficacy and safety of extended-release oxybutynin in combination with tamsulosin for treatment of lower urinary tract symptoms in men: randomized, double-blind, placebo-controlled study.
    Mayo Clinic proceedings, 2008, Volume: 83, Issue:9

    Topics: Aged; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Quality of Life; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Urodynamics

2008
Effects of serum PSA on efficacy of tolterodine extended release with or without tamsulosin in men with LUTS, including OAB.
    Urology, 2008, Volume: 72, Issue:5

    Topics: Adrenergic alpha-Antagonists; Aged; Benzhydryl Compounds; Cohort Studies; Cresols; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Predictive Value of Tests; Prostate-Specific Antigen; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urination Disorders

2008
Safety and tolerability of solifenacin add-on therapy to alpha-blocker treated men with residual urgency and frequency.
    The Journal of urology, 2009, Volume: 182, Issue:6

    Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Double-Blind Method; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Urinary Bladder, Overactive

2009
The effects of dutasteride, tamsulosin, and the combination on storage and voiding in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the Combination of Avodart and Tamsulosin study.
    Prostate cancer and prostatic diseases, 2009, Volume: 12, Issue:4

    Topics: Adrenergic alpha-Antagonists; Aged; Azasteroids; Double-Blind Method; Drug Therapy, Combination; Dutasteride; Enzyme Inhibitors; Humans; Male; Middle Aged; Prostatic Hyperplasia; Prostatism; Sulfonamides; Tamsulosin; Urinary Bladder, Overactive; Urination

2009
[Combination therapy with anticholinergics and alpha-blockers for the treatment of overactive bladder in female patients--pilot study].
    Ceska gynekologie, 2009, Volume: 74, Issue:6

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Benzilates; Cholinergic Antagonists; Drug Therapy, Combination; Female; Humans; Middle Aged; Sulfonamides; Tamsulosin; Urinary Bladder, Overactive; Urination

2009
Solifenacin as add-on therapy for overactive bladder symptoms in men treated for lower urinary tract symptoms--ASSIST, randomized controlled study.
    Urology, 2011, Volume: 78, Issue:1

    Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Double-Blind Method; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Prostatism; Quinuclidines; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Urinary Bladder, Overactive

2011
Urodynamic effects of the combination of tamsulosin and daily tadalafil in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: a randomized, placebo-controlled clinical trial.
    International urology and nephrology, 2013, Volume: 45, Issue:1

    Topics: Adrenergic alpha-1 Receptor Antagonists; Carbolines; Double-Blind Method; Drug Therapy, Combination; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Prostatism; Sulfonamides; Tadalafil; Tamsulosin; Urinary Bladder, Overactive; Urination; Urodynamics

2013
Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial.
    JAMA, 2006, Nov-15, Volume: 296, Issue:19

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Incontinence, Urge

2006
A randomized double-blind placebo-controlled multicentre study to explore the efficacy and safety of tamsulosin and tolterodine in women with overactive bladder syndrome.
    BJU international, 2007, Volume: 100, Issue:4

    Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Single-Blind Method; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urodynamics

2007

Other Studies

25 other study(ies) available for tamsulosin and Bladder, Overactive

ArticleYear
Discovery of 5-Chloro-1-(5-chloro-2-(methylsulfonyl)benzyl)-2-imino-1,2-dihydropyridine-3-carboxamide (TAK-259) as a Novel, Selective, and Orally Active α1D Adrenoceptor Antagonist with Antiurinary Frequency Effects: Reducing Human Ether-a-go-go-Related G
    Journal of medicinal chemistry, 2016, Apr-14, Volume: 59, Issue:7

    Topics: Administration, Oral; Adrenergic alpha-1 Receptor Antagonists; Animals; Chemistry Techniques, Synthetic; Cystitis; Disease Models, Animal; Drug Discovery; Drug Evaluation, Preclinical; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Imines; Molecular Docking Simulation; Mutagenesis, Site-Directed; Niacinamide; Rats; Receptors, Adrenergic, alpha-1; Structure-Activity Relationship; Urinary Bladder; Urinary Bladder Neck Obstruction; Urinary Bladder, Overactive

2016
Editorial Comment.
    The Journal of urology, 2020, Volume: 203, Issue:6

    Topics: Acetanilides; Humans; Male; Prostatic Hyperplasia; Tamsulosin; Thiazoles; Urinary Bladder, Overactive

2020
Cognitive functions and health-related quality of life in men with benign prostatic hyperplasia and symptoms of overactive bladder when treated with a combination of tamsulosin and solifenacin in a higher dosage.
    The aging male : the official journal of the International Society for the Study of the Aging Male, 2018, Volume: 21, Issue:2

    Topics: Aged; Case-Control Studies; Cognition; Cohort Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Male; Mental Status and Dementia Tests; Middle Aged; Prostatic Hyperplasia; Quality of Life; Solifenacin Succinate; Sulfonamides; Tamsulosin; Urinary Bladder, Overactive; Urological Agents

2018
Vesomni improves the quality of life in men with lower urinary tract symptoms in routine clinical practice in Europe.
    Neurourology and urodynamics, 2019, Volume: 38, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Drug Combinations; Europe; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Patient Satisfaction; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Solifenacin Succinate; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents

2019
Additional correction of OAB symptoms by two anti-muscarinics for men over 50 years old with residual symptoms of moderate prostatic obstruction after treatment with Tamsulosin.
    The aging male : the official journal of the International Society for the Study of the Aging Male, 2015, Volume: 18, Issue:1

    Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Benzilates; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Nortropanes; Prostatic Hyperplasia; Solifenacin Succinate; Sulfonamides; Tamsulosin; Urinary Bladder Neck Obstruction; Urinary Bladder, Overactive

2015
Persistence with solifenacin add-on therapy in men with benign prostate obstruction and residual symptoms of overactive bladder after tamsulosin monotherapy.
    International journal of clinical practice, 2014, Volume: 68, Issue:12

    Topics: Drug Therapy, Combination; Humans; Male; Muscarinic Antagonists; Prostatic Hyperplasia; Quinuclidines; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Urinary Bladder, Overactive

2014
Urodynamic Efficacy and Safety of Mirabegron Add-on Treatment with Tamsulosin for Japanese Male Patients with Overactive Bladder.
    Lower urinary tract symptoms, 2016, Volume: 8, Issue:3

    Topics: Acetanilides; Adrenergic beta-Agonists; Aged; Aged, 80 and over; Drug Therapy, Combination; Humans; Male; Middle Aged; Patient Safety; Prospective Studies; Sulfonamides; Tamsulosin; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive; Urination; Urodynamics; Urological Agents

2016
Editorial comment on: Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate size.
    European urology, 2009, Volume: 55, Issue:2

    Topics: Adrenergic alpha-Antagonists; Aged; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Humans; Male; Middle Aged; Muscarinic Agonists; Organ Size; Phenylpropanolamine; Prostate; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Tract; Urination

2009
Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate size.
    European urology, 2009, Volume: 55, Issue:2

    Topics: Adrenergic alpha-Antagonists; Adult; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Diuresis; Drug Therapy, Combination; Humans; Male; Middle Aged; Multicenter Studies as Topic; Muscarinic Agonists; Organ Size; Phenylpropanolamine; Prostate; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Retention

2009
Editorial comment on: Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate size.
    European urology, 2009, Volume: 55, Issue:2

    Topics: Adrenergic alpha-Antagonists; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Male; Muscarinic Agonists; Organ Size; Phenylpropanolamine; Prostate; Safety; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Urinary Bladder Neck Obstruction; Urinary Bladder, Overactive; Urologic Diseases

2009
[Examination of the mechanism of ameliorating effect of alpha 1-blocker on storage symptoms associated with benign prostatic hyperplasia].
    Hinyokika kiyo. Acta urologica Japonica, 2008, Volume: 54, Issue:6

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Female; Male; Prostatic Hyperplasia; Rabbits; Rats; Sulfonamides; Tamsulosin; Urinary Bladder, Overactive

2008
Re: Claus G. Roehrborn, Steven A. Kaplan, J. Stephen Jones, Joseph T. Wang, Tamara Bavendam, Zhonghong Guan. Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of
    European urology, 2009, Volume: 55, Issue:2

    Topics: Adrenergic alpha-Antagonists; Calcinosis; Humans; Inflammation; Male; Middle Aged; Prostate; Prostatic Diseases; Prostatitis; Sulfonamides; Tamsulosin; Urinary Bladder, Overactive; Urologic Diseases

2009
Role of alpha1-adrenergic receptors in detrusor overactivity induced by cold stress in conscious rats.
    Neurourology and urodynamics, 2009, Volume: 28, Issue:3

    Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Blood Pressure; Body Temperature; Cold Temperature; Female; Indoles; Naphthalenes; Piperazines; Prazosin; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Urinary Bladder; Urinary Bladder, Overactive

2009
Relationship between lower urinary tract symptoms and urinary ATP in patients with benign prostatic hyperplasia or overactive bladder.
    Biomedical research (Tokyo, Japan), 2009, Volume: 30, Issue:5

    Topics: Adenosine Triphosphate; Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Animals; Benzilates; Cholinergic Antagonists; Female; Humans; Male; Middle Aged; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Urinary Bladder, Overactive

2009
Pharmacological and genetic analysis of mechanisms underlying detrusor overactivity in rats.
    Neurourology and urodynamics, 2010, Volume: 29, Issue:1

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Afferent Pathways; Animals; Benzhydryl Compounds; Brain; Cerebral Infarction; Cresols; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Early Growth Response Protein 1; Excitatory Amino Acid Antagonists; Muscarinic Antagonists; Muscle Contraction; Nerve Fibers, Unmyelinated; Neuronal Plasticity; Phenylpropanolamine; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP1 Subtype; RNA, Messenger; Sulfonamides; Tamsulosin; Time Factors; Tolterodine Tartrate; Transcription, Genetic; Urinary Bladder; Urinary Bladder, Overactive

2010
Survey of overactive bladder symptoms influencing bother before and after treatment with tamsulosin hydrochloride in Japanese patients with benign prostatic hyperplasia.
    Urology, 2011, Volume: 78, Issue:5

    Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Humans; Male; Prostatic Hyperplasia; Severity of Illness Index; Sulfonamides; Tamsulosin; Urinary Bladder, Overactive

2011
Co-administration of an α(1) -blocker improves the efficacy and safety of antimuscarinic agents in rats with detrusor overactivity.
    International journal of urology : official journal of the Japanese Urological Association, 2011, Volume: 18, Issue:12

    Topics: Adrenergic alpha-1 Receptor Antagonists; Analysis of Variance; Animals; Disease Models, Animal; Diterpenes; Drug Therapy, Combination; Female; Infarction, Middle Cerebral Artery; Muscarinic Antagonists; Muscle Contraction; Organ Size; Quinuclidines; Rats; Rats, Sprague-Dawley; Solifenacin Succinate; Statistics, Nonparametric; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Urinary Bladder; Urinary Bladder, Overactive

2011
The mechanisms underlying α1-adrenoceptor antagonists and modulation of bladder function: an emerging role for changes in perfusion.
    The Journal of urology, 2011, Volume: 186, Issue:6

    Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Female; Sulfonamides; Tamsulosin; Urinary Bladder; Urinary Bladder, Overactive

2011
Effect of tamsulosin on bladder blood flow and bladder function in a rat model of bladder over distention/emptying induced bladder overactivity.
    The Journal of urology, 2011, Volume: 186, Issue:6

    Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Disease Models, Animal; Female; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Sulfonamides; Tamsulosin; Urinary Bladder; Urinary Bladder, Overactive

2011
Urethral syndrome: response to alpha-adrenergic blocking agents.
    International urogynecology journal and pelvic floor dysfunction, 2006, Volume: 17, Issue:6

    Topics: Adrenergic alpha-Antagonists; Adult; Depression; Female; Humans; Quinazolines; Remission Induction; Sulfonamides; Syndrome; Tamsulosin; Urinary Bladder, Overactive

2006
Role of peripheral 5-HT1A receptors in detrusor over activity associated with partial bladder outlet obstruction in female rats.
    European journal of pharmacology, 2007, Apr-30, Volume: 561, Issue:1-3

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic alpha-Antagonists; Animals; Dose-Response Relationship, Drug; Female; Hypertrophy; Piperazines; Pyridines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Receptors, Adrenergic, alpha-1; Serotonin Antagonists; Serotonin Receptor Agonists; Sulfonamides; Tamsulosin; Up-Regulation; Urinary Bladder Neck Obstruction; Urinary Bladder, Overactive

2007
Treatment of men with lower urinary tract symptoms and overactive bladder.
    JAMA, 2007, Mar-21, Volume: 297, Issue:11

    Topics: Adrenergic alpha-Antagonists; Aged; Benzhydryl Compounds; Cost-Benefit Analysis; Cresols; Drug Therapy, Combination; Humans; Male; Muscarinic Antagonists; Patient Satisfaction; Phenylpropanolamine; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge

2007
Treatment of men with lower urinary tract symptoms and overactive bladder.
    JAMA, 2007, Mar-21, Volume: 297, Issue:11

    Topics: Adrenergic Agonists; Adrenergic alpha-Antagonists; Aged; Benzhydryl Compounds; Cresols; Drug Interactions; Drug Therapy, Combination; Histamine H1 Antagonists; Humans; Male; Muscarinic Antagonists; Phenylpropanolamine; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Incontinence, Urge

2007
[A comparative study assessing clinical effects of naftopidil and tamsulosin hydrochloride on benign prostatic hyperplasia with overactive bladder].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2007, Volume: 98, Issue:5

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Drug Administration Schedule; Humans; Male; Middle Aged; Naphthalenes; Piperazines; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Bladder, Overactive

2007
Antimuscarinic drug inhibits detrusor overactivity induced by topical application of prostaglandin E2 to the urethra with a decrease in urethral pressure.
    The Journal of urology, 2007, Volume: 178, Issue:5

    Topics: Administration, Intravesical; Administration, Topical; Adrenergic alpha-Antagonists; Animals; Atropine; Benzilates; Calcium Channel Blockers; Cholinergic Antagonists; Dinoprostone; Disease Models, Animal; Female; Injections, Intra-Arterial; Muscarinic Antagonists; Muscle Contraction; omega-Conotoxins; Oxytocics; Pressure; Rats; Rats, Sprague-Dawley; Sulfonamides; Tamsulosin; Treatment Outcome; Urethra; Urinary Bladder; Urinary Bladder, Overactive; Verapamil

2007
chemdatabank.com